De Novo or Transformed Indolent B-cell Lymphoma
1 clinical trials · Condition
◉ Watch De Novo or Transformed Indolent B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas (NCT05583149) | Patrick C. Johnson, MD | 2023-03-01 |
Track De Novo or Transformed Indolent B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.